Grossman Adam S's Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Aug 27, 2024
- Accession no.
- 0001140361-24-038772
- Filed
- Aug 27, 2024
- Trade date
- Aug 26-27, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 7 derivative transactions. Open-market sales total $10.9M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grossman Adam SCIK 0001542517 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +64,405 | $3.35 | +$215,756.75 | 2,124,131 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +55,000 | $5.00 | +$275,000 | 2,179,131 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +16,984 | $5.96 | +$101,224.64 | 2,196,115 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +40,500 | $9.37 | +$379,485 | 2,236,615 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +60,000 | $10.80 | +$648,000 | 2,296,615 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −236,889 | $17.69 | −$4,190,566.41 | 2,059,726 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseAcquired | +341,960 | $3.35 | +$1,145,566 | 2,401,686 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseAcquired | +47,396 | $2.92 | +$138,396.32 | 2,449,082 | Direct | |
| Aug 27, 2024 | Common Stock | SSaleDisposed | −389,356 | $17.29 | −$6,731,965.24 | 2,059,726 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −64,405 | $3.35 | −$215,756.75 | 1,082,980 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −55,000 | $5.00 | −$275,000 | 0 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −16,984 | $5.96 | −$101,224.64 | 0 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −40,500 | $9.37 | −$379,485 | 0 | Direct | |
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −60,000 | $10.80 | −$648,000 | 0 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseDisposed | −341,960 | $3.35 | −$1,145,566 | 741,020 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseDisposed | −47,396 | $2.92 | −$138,396.32 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.